Login to Your Account



Search

Search results

Clinic roundup

Intercept Pharmaceuticals Inc. , of New York, presented results from the phase III POISE trial of obeticholic acid (OCA) for the treatment of primary biliary cirrhosis (PBC) at the International Liver Congress of the European Association of the Study ...

BioWorld Today - Staff - 2014-04-15 00:00 - 0 comments - 0 attachments

Clinic roundup

Dendreon Corp. , of Seattle, reported that preliminary data from a long-term analysis of the phase II STAND study suggested tumor-specific T-cell responses appear to be enhanced and sustained when Provenge (sipuleucel-T) is given following androgen d ...

BioWorld Today - Staff - 2014-04-14 00:00 - 0 comments - 0 attachments

Clinic roundup

Affimed Therapeutics AG , of Heidelberg, Germany, said results from a phase I trial of AFM13, its monotherapy for the treatment of patients with advanced relapsing/refractory Hodgkin lymphoma, confirmed the drug's safety in 28 heavily pretreated pati ...

BioWorld Today - Staff - 2014-04-11 00:00 - 0 comments - 0 attachments

Clinic roundup

Aegerion Pharmaceuticals Inc. , of Cambridge, Mass., said patient enrollment was initiated in Japan in a phase III trial of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in Japanese patients with homozygous ...

BioWorld Today - Staff - 2014-04-10 00:00 - 0 comments - 0 attachments

Clinic roundup

Oncolytics Biotech Inc. , of Calgary, Alberta, reported additional data from its phase III REO 018 study testing Reolysin in combination with carboplatin and paclitaxel in patients with second-line, platinum-refractory, taxane-naïve head and nec ...

BioWorld Today - Staff - 2014-04-09 00:00 - 0 comments - 0 attachments

Clinic roundup

Pacira Pharmaceuticals Inc. announced additional phase III data supporting the safety and efficacy of (bupivacaine liposome injectable suspension) to achieve a femoral nerve block in patients undergoing total knee arthroplasty. (BioWorld-To ...

BioWorld Today - Staff - 2014-04-08 00:00 - 0 comments - 0 attachments

Clinic roundup

Noxxon Pharma AG , of Berlin, said phase IIa proof-of-concept data from the emapticap pegol (NOX-E36) trial in diabetic nephropathy were presented at the ISN Nexus Symposium in Bergamo, Italy. (BioWorld-Today-2014-04-07) ...

BioWorld Today - Staff - 2014-04-07 00:00 - 0 comments - 0 attachments

Clinic roundup

Gilead Sciences Inc. , of Foster City Calif., said positive top-line results from a phase III trial evaluating Sovaldi (sofosbuvir) in combination with ribavirin for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection in Japan put i ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Clinic roundup

Cardiocell LLC , of San Diego, received investigational new drug approval from the FDA for a phase IIa study using its allogeneic stem cell therapy to treat patients with chronic heart failure (CHF). (BioWorld-Today-2014-04-03) ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments